1. Home
  2. BNR vs CAAS Comparison

BNR vs CAAS Comparison

Compare BNR & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$18.73

Market Cap

126.5M

Sector

Health Care

ML Signal

N/A

CAAS

China Automotive Systems Inc.

HOLD

Current Price

$4.90

Market Cap

134.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
CAAS
Founded
2014
N/A
Country
China
China
Employees
N/A
N/A
Industry
Medical Specialities
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
126.5M
134.9M
IPO Year
2019
2025

Fundamental Metrics

Financial Performance
Metric
BNR
CAAS
Price
$18.73
$4.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 60.4K
19.0K
Earning Date
06-05-2026
04-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$111.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$3.97
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$4.00
52 Week High
$41.72
$5.64

Technical Indicators

Market Signals
Indicator
BNR
CAAS
Relative Strength Index (RSI) 69.89 40.66
Support Level $15.61 $4.39
Resistance Level $18.59 $5.00
Average True Range (ATR) 1.75 0.16
MACD 0.53 -0.07
Stochastic Oscillator 81.45 1.35

Price Performance

Historical Comparison
BNR
CAAS

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm, through its subsidiary, is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series of power steering models, including rack and pinion power steering, integral power steering, electronic power steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: